Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Cancer with CRISPR/Cas9-Based Therapy
Katarzyna Balon, Adam Sheriff, J. Jackow, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 573-573
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
Mamello Sekhoacha, Keamogetswe Riet, Paballo Motloung, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5730-5730
Open Access | Times Cited: 418
Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 936-954
Open Access | Times Cited: 46
Advances and applications of nanoparticles in cancer therapy
Xianzhou Huang, Tao He, Xiuqi Liang, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 17
Triple coumarin-based 5-fluorouracil prodrugs, their synthesis, characterization, and release kinetics
Yasser Fakri Mustafa
Journal of Molecular Structure (2023) Vol. 1301, pp. 137415-137415
Closed Access | Times Cited: 24
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
Qi Wang, Zhangzuo Li, Shujing Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 23
Biomaterials-mediated CRISPR/Cas9 delivery: recent challenges and opportunities in gene therapy
Ankit Kumar Dubey, Ebrahim Mostafavi
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 19
Advances in Cancer Gene Therapy: Strategies, Delivery Methods, and Challenges
Anni Lepland, Kadi-Liis Veiman
Methods in pharmacology and toxicology (2025), pp. 105-123
Closed Access
Changes in the mammary gland during aging and its links with breast diseases
Junqiang Lin, Shihui Ye, Ke Hao, et al.
Acta Biochimica et Biophysica Sinica (2023) Vol. 55, Iss. 6, pp. 1001-1019
Open Access | Times Cited: 13
Systematic analysis of integrated bioinformatics to identify upregulated THBS2 expression in colorectal cancer cells inhibiting tumour immunity through the HIF1A/Lactic Acid/GPR132 pathway
Ye Liu, Chunhui Jiang, Chunjie Xu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Preclinical Anticipation of On- and Off-Target Resistance Mechanisms to Anti-Cancer Drugs: A Systematic Review
Paulina J. Dziubańska-Kusibab, Ekaterina Nevedomskaya, Bernard Haendler
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 705-705
Open Access | Times Cited: 4
State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer
Saravanan Ramesh, Preethi Selvakumar, Mohamed Yazeer Ameer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Decoding the regulatory landscape of lncRNAs as potential diagnostic and prognostic biomarkers for gastric and colorectal cancers
Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer
Shiva Shirani-Bidabadi, Aliye Tabatabaee, Nazita Tavazohi, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151299-151299
Open Access | Times Cited: 9
Viral delivery of CRISPR/Cas9 genome editing for rapid crop improvement: A promising approach to enhance crop resilience against biotic and abiotic stresses
Akshay Milind Patil, Sopan Ganpatrao Wagh, Ganesh B. Janvale, et al.
International Journal of Advanced Biochemistry Research (2024) Vol. 8, Iss. 3S, pp. 782-796
Open Access | Times Cited: 2
Role of microRNA-363 during tumor progression and invasion
Arya Nasimi Shad, Iman Akhlaghipour, Hawraa Ibrahim Alshakarchi, et al.
Journal of Physiology and Biochemistry (2024) Vol. 80, Iss. 3, pp. 481-499
Closed Access | Times Cited: 2
CRISPR, CAR-T, and NK: Current applications and future perspectives
Mohadeseh Khoshandam, Hossein Soltaninejad, Amir Ali Hamidieh, et al.
Genes & Diseases (2023) Vol. 11, Iss. 4, pp. 101121-101121
Open Access | Times Cited: 6
CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention
Ulrich H. Weidle, Adam Nopora
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 4, pp. 327-349
Open Access | Times Cited: 1
Pan-cancer analysis and single-cell analysis reveals FAM110B as a potential target for survival and immunotherapy
Yuwei Li, Xiaoxi Li, Bihua Wu, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
E3 ubiquitin ligase DTX2 fosters ferroptosis resistance via suppressing NCOA4-mediated ferritinophagy in non-small cell lung cancer
Zhuang Liu, Chang Liu, Caihong Fan, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101154-101154
Closed Access | Times Cited: 1
Microbial Therapeutics in Oncology: A Comprehensive Review of Bacterial Role in Cancer Treatment
Radha Kunjalwar, Akshunna Keerti, Achal Chaudhari, et al.
Cureus (2024)
Open Access | Times Cited: 1
Emerging Gene-editing nano-therapeutics for Cancer
Najma Nujoom, Manzoor Koyakutty, Lalitha Biswas, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39323-e39323
Open Access | Times Cited: 1
Silk Fibroin-Modified Liposome/Gene Editing System Knocks out the PLK1 Gene to Suppress the Growth of Lung Cancer Cells
Peng Pan, Xueping Liu, Mengqi Fang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2756-2756
Open Access | Times Cited: 2
Essential genes analysis reveals small ribosomal subunit protein eS28 may be a prognostic factor and potential vulnerability in osteosarcoma
Chao Liang, Juan Zhou, Yongjie Wang, et al.
Journal of bone oncology (2023) Vol. 44, pp. 100517-100517
Open Access | Times Cited: 2
Comparison of Clinical Efficacy of Molecular Targeted Drugs Combined with Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemoembolization Alone for Primary Liver Cancer
Xinru Sun, Bojiang Wang, Yin Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Crispr-cas System: Classification, Benefits, Applications And Function
Taha Nazir, Hameed A. Mirza, Nida Taha
(2024)
Open Access
Page 1 - Next Page

Scroll to top